American Hospital Dubai is an internationally accredited general medical-surgical hospital providing patient-centric healthcare and customer services across a wide range of clinical areas.

The 254-bed hospital campus is equipped with the most advanced imaging and diagnostic technology and treatments, with a multidisciplinary team of physicians who are either USA-board certified or Western equivalent.

The American Hospital Dubai is also the first hospital in the Middle East to be awarded Joint Commission International (JCI) accreditation. Its laboratory is the first private lab to earn accreditation from the College of American Pathologists (CAP).

The Cancer Care Center is the first comprehensive facility to offer a range of Medical Oncology and Hematology services for all forms of cancers and blood disorders--in addition to traditional cancer treatment options of Surgery, Chemotherapy, Radiation Therapy, Palliative care and new therapies.

The Heart & Vascular Center now includes a range of vascular services and an updated state of the art angiosuite. The center is able to diagnose, monitor and treat all types of heart conditions through invasive and non-invasive cardiology procedures, cardiothoracic surgery, and vascular surgery, supported by advanced rehabilitation services.

Platinum Sponsor

COMPREHENSIVE CANCER CENTRE AT MEDICLINIC CITY HOSPITAL
Delivering a Unique Service to Oncology Patients in the UAE

Mediclinic City Hospital's Comprehensive Cancer Centre (CCC), which opened in the new North Wing extension in September 2016, is the UAE’s most advanced facility for the diagnosis and treatment of cancer. It provides a range of facilities and services, supported by the latest generation of equipment, some of which are entirely new not only to the UAE but to the entire MENA region.

Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC can, for the first time in the UAE, benefit from the sharing of knowledge and experience between some of the leading oncology experts in Europe and the Middle East, as well as access to the very latest treatment programmes and technology.

The CCC combines diagnostic procedures with the treatment modalities of surgery, medical oncology and radiation therapy, all under one roof. The value of the service provided by the CCC stems from the quality of the technology and equipment it houses. The CCC offers radiation therapy using the first TrueBeam linear accelerator in the UAE, and the only Varian 13.7 version in the MENA region, using the newest treatment technology of flattening filter free energy.

BRISTOL-MYERS SQUIBB

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B, Hepatitis C, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.

References:www.bms.com

Gold Sponsors

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Silver Sponsor

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

Page being Updated

Internet Cafe Sponsor

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

Helixor Heilmittel GmbH is an international company in the field of integrative oncology. Our Mission: improving the quality of life of cancer patients.
The company’s headquarter is in Rosenfeld, south of Stuttgart, Germany.
Helixor is active internationally with affiliates in Canada, Brazil and, most recently, India, and also works with distribution partners and customers in over 20 countries around the world.
Helixor medicinal products are produced in a unique manufacturing process in line with GMP regulations. Continuous clinical and preclinical research, as well as cooperation with university hospitals, physicians and scientists, demonstrate the efficacy and safety of our products.

Sirtex Medical is actively engaged in the field of liver-directed therapies for cancer patients. Our innovative technology, SIR-Spheres® Y-90 resin microspheres (microscopic Yttrium-90 resin beads), are approved for use in several countries for the treatment of unresectable liver tumours. In the US, SIR-Spheres Y-90 resin microspheres have a Pre-Market Approval (PMA) from the FDA and are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy of Floxuridine.

SIR-Spheres® Y-90 resin microspheres are presently used at over 1000 institutions worldwide. To date, more than 70,000 treatments have been delivered globally.

®SIR-Spheres is a registered trademark of Sirtex SIR-Spheres Pty Ltd

Exhibitors


For Sponsorship and Exhibition inquiries, please contact Rakesh.Chhetri@mci-group.com